Cargando…
Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis
Polymorphism in the microglial receptor CD33 gene has been linked to late-onset Alzheimer disease (AD), and reduced expression of the CD33 sialic acid-binding domain confers protection. Thus, CD33 inhibition might be an effective therapy against disease progression. Progress toward discovery of sele...
Autores principales: | Miles, Luke A., Hermans, Stefan J., Crespi, Gabriela A.N., Gooi, Jonathan H., Doughty, Larissa, Nero, Tracy L., Markulić, Jasmina, Ebneth, Andreas, Wroblowski, Berthold, Oehlrich, Daniel, Trabanco, Andrés A., Rives, Marie-Laure, Royaux, Ines, Hancock, Nancy C., Parker, Michael W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669322/ https://www.ncbi.nlm.nih.gov/pubmed/31369984 http://dx.doi.org/10.1016/j.isci.2019.07.023 |
Ejemplares similares
-
Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation
por: Miles, Luke A., et al.
Publicado: (2013) -
ERRATUM: Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation
por: Miles, Luke A., et al.
Publicado: (2013) -
Repression of phagocytosis by human CD33 is not conserved with mouse CD33
por: Bhattacherjee, Abhishek, et al.
Publicado: (2019) -
Author Correction: Repression of phagocytosis by human CD33 is not conserved with mouse CD33
por: Bhattacherjee, Abhishek, et al.
Publicado: (2020) -
Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA
por: Ascher, David B., et al.
Publicado: (2014)